WASHINGTON - A bill aimed at streamlining the process of making certain prescription medicines available over the counter has been enacted into law.

The measure requires the Food and Drug Administration to improve the clarity and predictability of its review process when pharmaceutical companies seek to change a drug’s status from prescription to nonprescription.

Sen. Jon Husted, R-Ohio, who introduced the bill with Sen. Maggie Hassan, D-N.H., said the new law creates a clear road map for drug developers and the FDA.

The new law, which amends the Federal Food, Drug, and Cosmetic Act, focuses on standardizing the interactions between the agency and drug sponsors. It specifically directs the Food and Drug Administration to establish formal meetings to discuss applications for a status ch

See Full Page